Parameter
| Biomarker | ROS1 | Full name | c-ros Oncogene 1 | Molecular Type | Nucleic acid（DNA） |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Targeted therapy guidance |
| Disease | Non-Small Cell Lung Cancer | Disease Subtypes | / | ||
| Organ | Lung | Test Sample / Technology Platform | Tissue / Blood (Genetic Testing) | ||
| Pathobiological Mechanisms | Fusion genes drive tumors that are sensitive to ROS1 inhibitors | ||||
| Clinical Availability Status | Clinically available (targeted therapy screening) | ||||
| Notes and Dynamics | The incidence is 1%-2%, similar to the clinical features of ALK fusion, and the inhibitor effect is significant | ||||